AzurRx BioPharma Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

NEXT STORY
TRACON Pharmaceuticals Announces Appointment of Lisa Johnson-Pratt, M.D., to its Board of Directors
PREV STORY
OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patients with COVID-19 Pneumonia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cyclacel Pharmaceuticals Reports First Quarter 2021 Financial Results

author_avatar
NASDAQ Market News

de Beaumont Foundation Announces New Class of 40 Under 40 in Public Health

author_avatar
NASDAQ Market News

Biocartis Group NV: Biocartis en Bristol-Myers Squibb tekenen samenwerkingsovereenkomst voor MSI-testing met immuno-oncologietherapieën

author_avatar
NASDAQ Market News